iNtRON Biotechnology Inc

iNtRON Biotechnology, Inc. develops novel biopharmaceutical drugs in South Korea. It develops bacteriophage- and endolysin-based drugs through its itLysin and IMPA platforms. The company was founded in 1999 and is headquartered in Seongnam-si, South Korea.